Natera, Inc. (NTRA) Form 10-Q Quarterly Reports
Natera, Inc. (NTRA) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NTRA
CIK: 1604821
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKristen Pisani
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | 4 Filing | 0001646382-26-000023 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010241 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | 4 Filing | 0001646382-26-000022 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001711968-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0002010019-26-000030 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009948 | View SEC Doc Filr Page |
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009911 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 Filing | 0001646649-26-000033 | View SEC Doc Filr Page |
| 144 | 2026-09-23 | — | 144 Filing | 0001949846-26-000594 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | 4 Filing | 0002010019-26-000029 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | 4 Filing | 0001646649-26-000032 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001646382-26-000021 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009533 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-11 | 4 Filing | 0001646382-26-000019 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009345 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0002010019-26-000028 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001711968-26-000022 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0002010019-26-000027 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008891 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008885 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-06 | 4 Filing | 0002010135-26-000020 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-10 | 4 Filing | 0001646649-26-000030 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000080255-26-000548 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | 4 Filing | 0001646382-26-000018 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | 4 Filing | 0001646649-26-000029 | View SEC Doc Filr Page |